-
Stay Connected
Get the latest news on exciting speakers, workshops & learning opportunities at ISDE 2021.
Subscribe for Updates
Esophageal lichen planus is an uncommon inflammatory disorder that can cause progressive swallowing difficulty, food impaction, mucosal fragility, and esophageal narrowing. It is usually associated with lichen planus affecting the mouth, skin, scalp, nails, or genital mucosa, although esophageal disease may occasionally be the first recognized manifestation.
Because symptoms can resemble reflux, eosinophilic esophagitis, infection, or malignancy, diagnosis requires careful endoscopic assessment and targeted biopsies. Early recognition matters: untreated inflammation may lead to strictures and repeated procedures, while chronic mucosal injury may require individualized cancer surveillance.
Lichen planus is an immune-mediated condition in which T-cell inflammation targets epithelial tissues. In the esophagus, this process can produce mucosal sloughing, erosions, white lacy markings, friability, and scarring. The upper and middle esophagus are commonly involved, although any segment may be affected.
The condition is reported most often in middle-aged women with oral or cutaneous lichen planus. Dysphagia is the leading symptom, followed by odynophagia, chest discomfort, regurgitation, and weight loss. Symptoms may progress gradually, so a patient’s changing diet or recurrent food impaction should not be dismissed as routine reflux.
A detailed history should cover the speed of symptom progression, episodes of food obstruction, painful swallowing, reflux treatment, medication exposure, and prior endoscopic findings. Examination of the mouth, tongue, gums, scalp, nails, and genital skin can reveal subtle lesions that support the diagnosis.
Endoscopy may show white papules or reticular streaks, mucosal denudation, longitudinal furrows, erosions, bleeding with light contact, and proximal strictures. The mucosa may appear deceptively normal between active areas. Careful inspection is important because forceful instrumentation can worsen tissue injury.
Several biopsies should be obtained from abnormal areas and, when appropriate, from apparently unaffected mucosa. Histology may demonstrate a lichenoid lymphocytic infiltrate, basal cell degeneration, apoptotic keratinocytes, hypergranulosis, and subepithelial separation. Findings can be patchy, and superficial samples may fail to capture diagnostic changes.
Direct immunofluorescence may help distinguish lichen planus from autoimmune blistering disorders, but results are not always definitive. The diagnosis should combine clinical findings, endoscopic appearance, pathology, and evidence of lichen planus elsewhere on the body. Dermatology, gastroenterology, and pathology collaboration is particularly valuable in uncertain cases.
| Condition | Helpful Clues | Key Diagnostic Consideration |
|---|---|---|
| Esophageal lichen planus | Oral or skin lesions, proximal disease, fragile mucosa, strictures | Multiple biopsies and clinical correlation |
| Eosinophilic esophagitis | Atopy, rings, furrows, food impaction | Esophageal eosinophil density on biopsies |
| Esophageal pemphigoid or pemphigus | Blistering, extensive mucosal involvement | Immunofluorescence and serum testing |
| Candida esophagitis | Odynophagia, immunosuppression, adherent plaques | Fungal elements on brushings or biopsy |
| Reflux esophagitis | Heartburn, distal predominant inflammation | Response to acid suppression does not prove LP |
| Esophageal cancer | Progressive dysphagia, weight loss, focal mass or ulcer | Deep, targeted biopsy and staging |
There is no universally accepted treatment algorithm, so therapy should reflect disease severity, stricture formation, comorbidities, and involvement of other organs. A swallowed topical corticosteroid, such as budesonide or fluticasone, is commonly used to deliver anti-inflammatory medication directly to the esophagus. Patients need clear instructions on administration and should avoid eating or drinking for a period afterward according to the prescribing clinician’s directions.
Systemic corticosteroids may be considered for severe, rapidly progressive, or extensive disease. Steroid-sparing medicines, including mycophenolate mofetil, azathioprine, methotrexate, or other immunomodulators, have been used when symptoms persist or steroid exposure becomes problematic. Evidence is based largely on case series and specialist experience, so treatment should be supervised by clinicians familiar with immune-mediated esophageal disease.
Acid suppression may protect against coexisting gastroesophageal reflux and support mucosal healing, but it does not treat the underlying lichenoid inflammation. Oral, genital, ocular, or skin disease should be managed at the same time, with referrals to dermatology, oral medicine, gynecology, or ophthalmology when indicated.
Fibrotic narrowing can make swallowing difficult even after active inflammation improves. Endoscopic dilation may restore the esophageal lumen, but it should be performed cautiously because inflamed, fragile tissue carries a higher risk of tearing or perforation. Gradual dilation, experienced operators, and ongoing anti-inflammatory treatment can reduce complications and recurrence.
Patients should receive urgent assessment for complete food impaction, inability to swallow liquids, vomiting blood, severe chest pain, or signs of perforation. Nutritional review is useful when a restricted diet, weight loss, or repeated procedures affect intake. Recurrent strictures often require coordinated planning rather than dilation alone.
Symptoms, nutritional status, endoscopic appearance, and treatment toxicity should be reviewed regularly. Repeat endoscopy is guided by symptoms, persistent narrowing, inadequate treatment response, or concern for dysplasia. Any new focal ulcer, mass, unexplained bleeding, or sudden change in swallowing requires prompt investigation.
Chronic esophageal inflammation has been associated with an increased risk of esophageal squamous cell carcinoma, although the absolute risk and ideal surveillance interval remain uncertain. Clinicians should document risk factors, biopsy suspicious lesions, and individualize surveillance rather than applying a rigid schedule to every patient.
Education from specialist meetings and esophageal disease research can support consistent recognition of this rare disorder. Clinicians caring for patients with persistent dysphagia or mucosal lichen planus should include esophageal involvement in the differential diagnosis and arrange coordinated evaluation before complications become established.